Pictured: Steven M. Horwitz
Video
By Esther Napolitano, BS, Science Writer/Editor  |  Friday, January 31, 2014

A recent web chat features medical oncologist Steven M. Horwitz discussing advances in the diagnosis and treatment of lymphoma.

Pictured: Anas Younes, Joachim Yahalom & Ahmet Dogan
Video
By Helen Garey, MPH, Freelance Writer  |  Tuesday, December 31, 2013

Lymphoma experts at Memorial Sloan Kettering discuss new directions in the diagnosis and treatment of this type of cancer.

Pictured: Ross Levine
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, December 9, 2013

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

Pictured: Anas Younes, Chief, Lymphoma Service
Profile
By Jim Stallard, MA, Writer/Editor  |  Wednesday, October 30, 2013

Medical oncologist Anas Younes leads an ambitious effort to find disease biomarkers that could predict which lymphoma patients will benefit from new targeted therapies.

Pictured: Sergio Giralt & Robin Roberts
Event
By Jim Stallard, MA, Writer/Editor  |  Thursday, October 17, 2013

Robin Roberts celebrated with more than 200 fellow stem cell transplant patients at Memorial Sloan Kettering’s annual Stem Cell Transplant Survivors Celebration.

Pictured: Andromachi Scaradavou
Ask the Expert
By Jim Stallard, MA, Writer/Editor  |  Wednesday, July 24, 2013

In this “Ask the Expert” feature, pediatric hematologist Andromachi Scaradavou discusses options for expectant parents who are considering banking a newborn’s cord blood.

Pictured: Halina Frydman
Patient Story
By Memorial Sloan Kettering  |  Monday, February 13, 2012

Soon after Halina Frydman’s husband noticed changes in his wife's personality, Halina was diagnosed with primary central nervous system lymphoma. She came to Memorial Sloan Kettering to receive treatment through a clinical trial.

Pictured: Hans-Guido Wendel
Profile
By Jim Stallard, MA, Writer/Editor  |  Tuesday, December 20, 2011

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.

Center News

Stay Informed

Get the latest information about cancer care and research every month.